Dupilumab for Severe Pediatric Atopic Dermatitis

from HCPLive Podcasts · host HCPLive.com

Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.

Episode metadata supplied by the publisher feed · Published Apr 4, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Dupilumab for Severe Pediatric Atopic Dermatitis

0:00 13:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of HCPLive Podcasts?

This episode is 13 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on April 4, 2020.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!